All Information (Except Text) for H.Amdt.799 to H.R.6115th Congress (2017-2018)
As of 03/23/2019 the description for this amendment has not been received.
An amendment numbered 3 printed in Part B of House Report 115-766 to direct the Commissioner of Food and Drugs to develop high-quality, evidence-based opioid analgesic prescribing guidelines for the indication-specific treatment of acute pain. In developing such guidelines, it requires the Commissioner of Food and Drugs to gather input through a public workshop and comment period, and to provide a report to Congress on how such guidelines will be used to protect the public health.
House Amendment Code:
House Tally Clerks use this code to manage amendment information.
|06/22/2018||On agreeing to the Barton amendment (A003) Agreed to by voice vote. |
|06/22/2018||Amendment (A003) offered by Mr. Barton. (consideration: CR H5562-5563; text: CR H5562-5563)|
06/22/2018 On agreeing to the Barton amendment (A003) Agreed to by voice vote.
06/22/2018 Amendment (A003) offered by Mr. Barton. (consideration: CR H5562-5563; text: CR H5562-5563)